Ptprf-KO 基因敲除小鼠

1. Soulières, Denis, Hirsch, Fred R, Shepherd, Frances A, Shames, David S, Klughammer, Barbara. . PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non-Small-Cell Lung Cancer. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 10, 1364-1369. doi:10.1097/JTO.0000000000000624. https://pubmed.ncbi.nlm.nih.gov/26291013/

2. Ausavarat, Surasawadee, Tongkobpetch, Siraprapa, Praphanphoj, Verayuth, Suphapeetiporn, Kanya, Shotelersuk, Vorasuk. 2011. PTPRF is disrupted in a patient with syndromic amastia. In BMC medical genetics, 12, 46. doi:10.1186/1471-2350-12-46. https://pubmed.ncbi.nlm.nih.gov/21453473/

3. Borck, Guntram, de Vries, Liat, Wu, Hsin-Jung, Kubisch, Christian, Basel-Vanagaite, Lina. 2014. Homozygous truncating PTPRF mutation causes athelia. In Human genetics, 133, 1041-7. doi:10.1007/s00439-014-1445-1. https://pubmed.ncbi.nlm.nih.gov/24781087/

4. Gan, Tong, Stevens, Ashley T, Xiong, Xiaopeng, Evers, B Mark, Gao, Tianyan. 2020. Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer. In Oncogene, 39, 6789-6801. doi:10.1038/s41388-020-01472-z. https://pubmed.ncbi.nlm.nih.gov/32973331/